ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
- PMID: 39846525
- PMCID: PMC11755583
- DOI: 10.3390/pediatric17010010
ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
Abstract
The aim of our study was to investigate the role of ABCB1 polymorphism in the pharmacokinetics of carbamazepine (CBZ) in children. The study enrolled 47 Serbian pediatric epileptic patients on CBZ treatment. Genotyping for ABCB1 1236C<T (rs1128503), 2677G<A/T (rs2032582) and 3435C<T (rs1045642) was carried out using the TaqMan method. Steady-state CBZ serum concentrations were available from our previous study, determined by high pressure liquid chromatography (HPLC). The NONMEM software and one-compartment model were used for pharmacokinetic analysis. ABCB1 1236C<T, 2677G<A/T and 3435C<T variations were found at the frequencies of 47.9%, 48.9% and 52.1%, respectively. The equation that described population clearance (CL) was CL (L/h) = 0.175 + 0.0403 × SEX + 0.0332 × ABCB1 + 0.0176 × CYP1A2 + 0.000151 × DD where SEX has a value of 1 if male and 0 if female, ABCB1 has a value of 1 if C-G-C/T-T-T and 0 if any other ABCB1 diplotype, CYP1A2 has a value of 1 if -163A/A and 0 if -163C/C or C/A, and DD is the total CBZ daily dose (mg/day). The presence of the ABCB1 1236T-2677T-3435T haplotype is associated with an increased clearance of CBZ in pediatric epileptic patients.
Keywords: ABCB1; carbamazepine; children; genetic polymorphism; population pharmacokinetics.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Similar articles
-
CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.Eur J Clin Pharmacol. 2016 Apr;72(4):439-45. doi: 10.1007/s00228-015-2006-9. Epub 2016 Jan 14. Eur J Clin Pharmacol. 2016. PMID: 26762380
-
Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid.Arch Dermatol Res. 2018 Aug;310(6):515-522. doi: 10.1007/s00403-018-1842-8. Epub 2018 Jun 9. Arch Dermatol Res. 2018. PMID: 29948283 Free PMC article.
-
Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients.Front Genet. 2020 Aug 11;11:889. doi: 10.3389/fgene.2020.00889. eCollection 2020. Front Genet. 2020. PMID: 32849848 Free PMC article.
-
ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.Gene. 2021 Dec 30;805:145907. doi: 10.1016/j.gene.2021.145907. Epub 2021 Aug 16. Gene. 2021. PMID: 34411648 Review.
-
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.Clin Pharmacokinet. 2010 Mar;49(3):141-75. doi: 10.2165/11317350-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20170205 Review.
References
-
- Zybina A., Anshakova A., Malinovskaya J., Melnikov P., Baklaushev V., Chekhonin V., Maksimenko O., Titov S., Balabanyan V., Kreuter J., et al. Nanoparticle-based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy. Int. J. Pharm. 2018;547:10–23. doi: 10.1016/j.ijpharm.2018.05.023. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases